Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Biotech Drug Industry Outpaces Rest Of Asia

This article was originally published in PharmAsia News

Executive Summary

The biotech drug industry in China has been growing by about 30 percent a year for the past two years, thanks to Chinese government efforts, industry experts say. They cite government support such as changes in regulation favorable to biopharmaceutical development. With that and its large patient population available for clinical trials, the country has become the fastest-growing in Asia in that sector, with the industry registering a 45 percent growth in sales last year. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068175

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel